Sinew Pharma Inc. (TPEX:6634)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
45.65
-0.80 (-1.72%)
Oct 9, 2025, 2:50 PM CST
-1.72%
Market Cap3.26B
Revenue (ttm)n/a
Net Income (ttm)-141.91M
Shares Out71.32M
EPS (ttm)-1.99
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,070
Average Volume51,395
Open46.50
Previous Close46.45
Day's Range44.85 - 46.50
52-Week Range34.30 - 60.00
Beta-0.04
RSI40.85
Earnings DateNov 14, 2025

About Sinew Pharma

Sinew Pharma Inc., a biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company’s products include SNP-610 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan; and SNP-630 drug, for which is in Phase II clinical trial. It is also developing SNP-810 is in phase II clinical trial for use in Pain relief and fever reduction; SNP-820 is in Phase II clinical trial for antidote for acetamino... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 52
Stock Exchange Taipei Exchange
Ticker Symbol 6634
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.